Evidence map›Paper›PMID 36969302›Full record

ArticleJournal of orthopaedics2023

Survey of blood flow restriction therapy for rehabilitation in Sports Medicine patients.

Joshua P Castle, Joseph S Tramer, Elizabeth H G Turner, Daniel Cotter, Anna McGee, Muhammad J Abbas, Matthew A Gasparro, T Sean Lynch, Vasilios Moutzouros

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of orthopaedics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06636045 (Effect of Blood Flow Restriction), which is not on this map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06636045 enrolling by invitationnot on this mapstarted 2024, after this paper: background citation

Effect of Blood Flow Restriction (BFR) on Rehabilitation Protocols Following Anterior Cruciate Ligament Reconstruction (ACLR) With Quadricep Autograft

Typeobservational_patient_registrySponsorUniversity of Kansas Medical CenterRan2024 to 2027Enrolled40ConditionsAutografts, Blood Flow Restriction Therapy, Rehabilitation Outcome, Quadriceps Muscle StrengthArmsNot applicable- observational study
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Joshua P CastleDepartment of Orthopaedic Surgery, Henry Ford Hospital, 2799 W Grand Boulevard, Detroit, MI, 48202, USA.
Joseph S TramerDepartment of Orthopaedic Surgery, Henry Ford Hospital, 2799 W Grand Boulevard, Detroit, MI, 48202, USA.
Elizabeth H G TurnerDepartment of Orthopaedic Surgery, Henry Ford Hospital, 2799 W Grand Boulevard, Detroit, MI, 48202, USA.
Daniel CotterDepartment of Orthopaedic Surgery, Henry Ford Hospital, 2799 W Grand Boulevard, Detroit, MI, 48202, USA.
Anna McGeeDepartment of Orthopaedic Surgery, Henry Ford Hospital, 2799 W Grand Boulevard, Detroit, MI, 48202, USA.
Muhammad J AbbasDepartment of Orthopaedic Surgery, Henry Ford Hospital, 2799 W Grand Boulevard, Detroit, MI, 48202, USA.
Matthew A GasparroDepartment of Orthopaedic Surgery, Henry Ford Hospital, 2799 W Grand Boulevard, Detroit, MI, 48202, USA.
T Sean LynchDepartment of Orthopaedic Surgery, Henry Ford Hospital, 2799 W Grand Boulevard, Detroit, MI, 48202, USA.
Vasilios MoutzourosDepartment of Orthopaedic Surgery, Henry Ford Hospital, 2799 W Grand Boulevard, Detroit, MI, 48202, USA.
Henry Ford Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Blood flow restriction (BFR) therapy has demonstrated benefits across a spectrum of musculoskeletal injuries, including improved strength, endurance, function, and reduction in pain perception. There is, however, no standardized application of BFR therapy among orthopaedic surgeons within the United States (US). Hypothesis: The indication and protocol for BFR therapy vary significantly across providers in the US. Methods: An online survey of 21 multiple-choice questions was sent to 3,281 surgeons listed on a large orthopaedic registry. A cross-sectional study was performed on all surgeons who successfully completed the questionnaire. Surgeons were queried on current or planned use of BFR, indications, contraindications, and peri-operative and non-operative management of sports-related injuries. Results: Overall, 250 physicians completed the survey, with 149 (59.8%) reporting current BFR use and 75.2% initiating use in the last 1-5 years. Most protocols (78.8%) utilize the modality 2-3 times per week while 15.9% use it only once weekly. Anterior cruciate ligament reconstruction (ACLR) rehabilitation was the most reported indication for initiating BFR therapy (95.7%) along with medial patellofemoral ligament reconstruction (70.2%), multiligamentous knee reconstruction (68.8%), meniscus repair (62.4%), collateral ligament reconstruction (50.4%), Achilles tendon repairs (30.5%), and meniscectomy (27%). Only 36.5% reported using BFR after upper extremity procedures, such as distal biceps repair (19.7%), ulnar collateral ligament elbow reconstruction (17%), rotator cuff (16.8%), and shoulder labrum repair (15.3%). For non-operative injuries, 65.8% of surgeons utilized BFR. Of those not currently using BFR therapy, 33.3% intended to implement its use in the future. Conclusion: BFR therapy has increased in popularity with most physicians implementing its use in the last 5 years. BFR was commonly utilized after ACLR. Clinical relevance: BFR allows light-load resistance to simulate high-intensity resistance training. This study describes US orthopaedic surgeons' common practice patterns and patient populations that utilize BFR therapy.

Indexed as

Anterior cruciate ligamentBlood flow restrictionNon-operative managementRehabilitation

Identifiers

PMID36969302
PMCPMC10030811
OpenAlexW4324044584

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.